BRPI0614867A2 - anticorpo quimérico ou uma porção de ligação de antìgeno do mesmo, método para produzir um anticorpo quimérico ou uma porção de ligação de antìgeno do mesmo, e, kit - Google Patents
anticorpo quimérico ou uma porção de ligação de antìgeno do mesmo, método para produzir um anticorpo quimérico ou uma porção de ligação de antìgeno do mesmo, e, kit Download PDFInfo
- Publication number
- BRPI0614867A2 BRPI0614867A2 BRPI0614867-0A BRPI0614867A BRPI0614867A2 BR PI0614867 A2 BRPI0614867 A2 BR PI0614867A2 BR PI0614867 A BRPI0614867 A BR PI0614867A BR PI0614867 A2 BRPI0614867 A2 BR PI0614867A2
- Authority
- BR
- Brazil
- Prior art keywords
- thr
- antigen binding
- binding portion
- ser
- pro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005904406A AU2005904406A0 (en) | 2005-08-15 | New World Antibodies | |
AU2005904406 | 2005-08-15 | ||
PCT/AU2006/001166 WO2007019621A1 (en) | 2005-08-15 | 2006-08-15 | Chimeric antibodies with new world primate regions |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0614867A2 true BRPI0614867A2 (pt) | 2012-01-31 |
Family
ID=37757238
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0614867-0A BRPI0614867A2 (pt) | 2005-08-15 | 2006-08-15 | anticorpo quimérico ou uma porção de ligação de antìgeno do mesmo, método para produzir um anticorpo quimérico ou uma porção de ligação de antìgeno do mesmo, e, kit |
BRPI0614430-6A BRPI0614430A2 (pt) | 2005-08-15 | 2006-08-15 | anticorpo ou uma porção de ligação de antìgeno do mesmo, e, kit |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0614430-6A BRPI0614430A2 (pt) | 2005-08-15 | 2006-08-15 | anticorpo ou uma porção de ligação de antìgeno do mesmo, e, kit |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1945669A4 (xx) |
JP (1) | JP2009504686A (xx) |
KR (1) | KR20080068005A (xx) |
CN (2) | CN101287762A (xx) |
AU (1) | AU2006281981A1 (xx) |
BR (2) | BRPI0614867A2 (xx) |
CA (1) | CA2619245A1 (xx) |
MX (1) | MX2008002161A (xx) |
NO (1) | NO20080800L (xx) |
NZ (1) | NZ565904A (xx) |
RU (1) | RU2008110058A (xx) |
WO (1) | WO2007019621A1 (xx) |
ZA (2) | ZA200802247B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007001015A (es) | 2004-07-26 | 2007-04-12 | Biogen Idec Inc | Anticuerpos anti-cd154. |
AU2007211829C9 (en) | 2006-02-01 | 2013-07-11 | Cephalon Australia Pty Ltd | Domain antibody construct |
PL2125894T3 (pl) * | 2007-03-22 | 2019-08-30 | Biogen Ma Inc. | Białka wiążące, w tym przeciwciała, pochodne przeciwciał i fragmenty przeciwciał, które swoiście wiążą się z CD154 i ich zastosowania |
EP2318436A4 (en) * | 2008-08-14 | 2012-12-19 | Cephalon Australia Pty Ltd | ANTIBODIES OF DIFFERENT DOMAINS |
RU2519862C2 (ru) * | 2010-08-06 | 2014-06-20 | Олег Ильич Эпштейн | Комплексное лекарственное средство и способ профилактики и лечения инфекционных вирусных заболеваний |
RU2505312C2 (ru) * | 2010-08-06 | 2014-01-27 | Олег Ильич Эпштейн | Комплексное лекарственное средство для лечения гриппа различных типов |
RU2535033C2 (ru) * | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
RU2535034C2 (ru) * | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
RU2502521C2 (ru) * | 2010-08-06 | 2013-12-27 | Олег Ильич Эпштейн | Комплексное лекарственное средство для лечения бактериальных инфекций и способ лечения бактериальных инфекций |
RU2516931C2 (ru) * | 2010-08-06 | 2014-05-20 | Олег Ильич Эпштейн | Способ и композиция для профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
RU2577299C2 (ru) * | 2011-07-04 | 2016-03-10 | Олег Ильич Эпштейн | Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний |
RU2521392C2 (ru) * | 2010-08-06 | 2014-06-27 | Олег Ильич Эпштейн | Комплексное лекарственное средство для лечения вирусных заболеваний и способ лечения вирусных заболеваний |
RU2517085C2 (ru) * | 2010-08-06 | 2014-05-27 | Олег Ильич Эпштейн | Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
RU2579262C1 (ru) * | 2014-10-02 | 2016-04-10 | Мапикс Эс.Эй.Ар.Эл. | Лекарственное средство для лечения инфекционных заболеваний |
CL2015002152A1 (es) * | 2015-07-31 | 2016-06-03 | Pontificia Universidad Católica De Chile | Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0137806B1 (ko) * | 1991-07-25 | 1998-04-30 | 케네쓰 제이. 울코트 | 사람의 질병 치료를 위한 재조합 항체 |
US6569431B2 (en) * | 2000-10-17 | 2003-05-27 | The Regents Of The University Of California | Recombinant antibody fragments as autoantibody antagonists |
US7235643B2 (en) * | 2000-11-07 | 2007-06-26 | Morphotek, Inc. | Antibodies and methods for generating genetically altered antibodies with high affinity |
AU2003244817B2 (en) * | 2002-06-28 | 2010-08-26 | Domantis Limited | Antigen-binding immunoglobulin single variable domains and dual-specific constructs |
JP2007534305A (ja) * | 2003-11-07 | 2007-11-29 | アムジェン インコーポレイテッド | サル免疫グロブリン配列 |
-
2006
- 2006-08-15 EP EP06774813A patent/EP1945669A4/en not_active Withdrawn
- 2006-08-15 CN CNA2006800381577A patent/CN101287762A/zh active Pending
- 2006-08-15 CN CNA2006800382565A patent/CN101287763A/zh active Pending
- 2006-08-15 NZ NZ565904A patent/NZ565904A/en not_active IP Right Cessation
- 2006-08-15 CA CA002619245A patent/CA2619245A1/en not_active Abandoned
- 2006-08-15 MX MX2008002161A patent/MX2008002161A/es not_active Application Discontinuation
- 2006-08-15 BR BRPI0614867-0A patent/BRPI0614867A2/pt not_active IP Right Cessation
- 2006-08-15 BR BRPI0614430-6A patent/BRPI0614430A2/pt not_active IP Right Cessation
- 2006-08-15 KR KR1020087006270A patent/KR20080068005A/ko not_active Application Discontinuation
- 2006-08-15 AU AU2006281981A patent/AU2006281981A1/en not_active Abandoned
- 2006-08-15 ZA ZA200802247A patent/ZA200802247B/xx unknown
- 2006-08-15 RU RU2008110058/13A patent/RU2008110058A/ru not_active Application Discontinuation
- 2006-08-15 JP JP2008526323A patent/JP2009504686A/ja active Pending
- 2006-08-15 WO PCT/AU2006/001166 patent/WO2007019621A1/en active Application Filing
- 2006-08-15 ZA ZA200802246A patent/ZA200802246B/xx unknown
-
2008
- 2008-02-14 NO NO20080800A patent/NO20080800L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2006281981A1 (en) | 2007-02-22 |
EP1945669A1 (en) | 2008-07-23 |
EP1945669A4 (en) | 2009-07-22 |
ZA200802246B (en) | 2009-09-30 |
RU2008110058A (ru) | 2009-09-27 |
CN101287763A (zh) | 2008-10-15 |
JP2009504686A (ja) | 2009-02-05 |
WO2007019621A1 (en) | 2007-02-22 |
CN101287762A (zh) | 2008-10-15 |
KR20080068005A (ko) | 2008-07-22 |
MX2008002161A (es) | 2008-04-22 |
NZ565904A (en) | 2012-02-24 |
ZA200802247B (en) | 2009-08-26 |
NO20080800L (no) | 2008-05-09 |
CA2619245A1 (en) | 2007-02-22 |
BRPI0614430A2 (pt) | 2011-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0614867A2 (pt) | anticorpo quimérico ou uma porção de ligação de antìgeno do mesmo, método para produzir um anticorpo quimérico ou uma porção de ligação de antìgeno do mesmo, e, kit | |
US20080095767A1 (en) | Engineered antibodies with new world primate framework regions | |
RU2765306C2 (ru) | Антитело против в7-н3, его антигенсвязывающий фрагмент и их медицинское применение | |
US7083784B2 (en) | Molecules with extended half-lives, compositions and uses thereof | |
US20080255343A1 (en) | Chimeric antibodies | |
JP5259423B2 (ja) | ドメイン抗体構築物 | |
US7981414B2 (en) | Anti-inflammatory dAb | |
MXPA03000201A (es) | Anticuerpos para mcp-1 humana. | |
JP2009525031A5 (xx) | ||
AU2014269287A1 (en) | Anti-TNF-alpha/CXCL10 double-targeting antibody and use thereof | |
MX2008002162A (en) | Engineered antibodies with new world primate framework regions | |
AU2021358662A1 (en) | CD1a ANTIBODIES AND USES THEREOF | |
CN113166273A (zh) | 具有il-7活性的双功能分子 | |
BRPI0620115A2 (pt) | anticorpo de domìnio recombinante, molécula de ácido nucleico isolada, composição farmacêutica, e, métodos para detectar o tnf-alfa humano em uma amostra e para tratar de um distúrbio distinguido pela atividade do tnf-alfa humano em um indivìduo humano | |
MX2008008029A (es) | Dab antiinflamatorio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: ARANA THERAPEUTICS PTY LTD. (AU) Free format text: NOME ALTERADO DE: ARANA THERAPEUTICS LIMITED |
|
B25D | Requested change of name of applicant approved |
Owner name: CEPHALON AUSTRALIA PTY LTD. (AU) Free format text: NOME ALTERADO DE: ARANA THERAPEUTICS PTY LTD. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUI DADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2214 DE 11/06/2013. |